{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T05:48:52Z","timestamp":1778305732831,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T00:00:00Z","timestamp":1641081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopha.2022.112614","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T21:53:36Z","timestamp":1641246816000},"page":"112614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells"],"prefix":"10.1016","volume":"147","author":[{"given":"Sepideh","family":"Zununi Vahed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mahdi","family":"Hosseiniyan Khatibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Ardalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10270","key":"10.1016\/j.biopha.2022.112614_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2022.112614_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"issue":"65","key":"10.1016\/j.biopha.2022.112614_bib3","doi-asserted-by":"crossref","first-page":"eabk1741","DOI":"10.1126\/sciimmunol.abk1741","article-title":"Immune signatures underlying post-acute COVID-19 lung sequelae","volume":"6","author":"Cheon","year":"2021","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112614_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-021-01628-9","article-title":"Tracking the time course of pathological patterns of lung injury in severe COVID-19","volume":"22","author":"Mauad","year":"2021","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.112614_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00428-020-02934-1","article-title":"Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems","volume":"478","author":"Barisione","year":"2021","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.biopha.2022.112614_bib6","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jinf.2020.09.027","article-title":"The potential indicators for pulmonary fibrosis in survivors of severe COVID-19","volume":"82","author":"Huang","year":"2021","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.biopha.2022.112614_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jrid.2020.07.002","article-title":"Follow-up study of clinical and chest CT scans in confirmed COVID-19 patients","volume":"7","author":"Deng","year":"2020","journal-title":"Radiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2022.112614_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/his.14249","article-title":"Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China","volume":"78","author":"Li","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.biopha.2022.112614_bib9","first-page":"1","article-title":"COVID-19 patients with pulmonary fibrotic tissue: clinical pharmacological rational of antifibrotic therapy","author":"Vitiello","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"10.1016\/j.biopha.2022.112614_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coviro.2017.11.001","article-title":"Formation and function of tissue-resident memory T cells during viral infection","volume":"28","author":"Shin","year":"2018","journal-title":"Curr. Opin. Virol."},{"issue":"36","key":"10.1016\/j.biopha.2022.112614_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw1217","article-title":"PD-1(hi) CD8(+) resident memory T cells balance immunity and fibrotic sequelae","volume":"4","author":"Wang","year":"2019","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112614_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41590-018-0298-5","article-title":"Hobit- and Blimp-1-driven CD4(+) tissue-resident memory T cells control chronic intestinal inflammation","volume":"20","author":"Zundler","year":"2019","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112614_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ajpath.2016.11.002","article-title":"Demonstration of tissue resident memory CD8 T cells in insulitic lesions in adult patients with recent-onset type 1 diabetes","volume":"187","author":"Kuric","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.biopha.2022.112614_bib14","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells","volume":"141","author":"Machado-Santos","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.biopha.2022.112614_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41423-019-0359-1","article-title":"Local heroes or villains: tissue-resident memory T cells in human health and disease","volume":"17","author":"Sasson","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2022.112614_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636118","article-title":"Age-related dynamics of lung-resident memory CD8(+) T cells in the age of COVID-19","volume":"12","author":"Goplen","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2022.112614_bib17","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.4049\/jimmunol.2100608","article-title":"Cutting edge: lung-resident T cells elicited by SARS-CoV-2 do not mediate protection against secondary infection","volume":"207","author":"Roberts","year":"2021","journal-title":"J. Immunol."},{"issue":"6515","key":"10.1016\/j.biopha.2022.112614_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2022.112614_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109414","article-title":"Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19","volume":"36","author":"Neidleman","year":"2021","journal-title":"Cell Rep."},{"issue":"56","key":"10.1016\/j.biopha.2022.112614_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf6692","article-title":"Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients","volume":"6","author":"Zhao","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2022.112614_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110152","article-title":"The importance of cell-mediated immunity in COVID-19 \u2013 an opinion","volume":"143","author":"Iqbal","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2022.112614_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.112614_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/272359","article-title":"The complex role of STAT3 in viral infections","volume":"2015","author":"Kuchipudi","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2022.112614_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000508247","article-title":"JAK inhibition as a new treatment strategy for patients with COVID-19","volume":"181","author":"Seif","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112614_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.biopha.2022.112614_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.112614_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamadermatol.2017.0001","article-title":"Treatment of alopecia areata with tofacitinib","volume":"153","author":"Ibrahim","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112614_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.112614_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"4","key":"10.1016\/j.biopha.2022.112614_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40121-020-00326-1","article-title":"Interleukin-6 blocking vs. JAK-STAT inhibition for prevention of lung injury in patients with COVID-19","volume":"9","author":"Meletiadis","year":"2020","journal-title":"Infect. Dis. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2022.112614_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/00325481.2020.1855921","article-title":"JAK-STAT pathway inhibition and their implications in COVID-19 therapy","volume":"133","author":"Satarker","year":"2021","journal-title":"Postgrad. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.112614_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000510179","article-title":"JAK\/STAT pathway inhibition may be a promising therapy for COVID-19-related hyperinflammation in hematologic patients","volume":"144","author":"Rojas","year":"2021","journal-title":"Acta Haematol."},{"issue":"8","key":"10.1016\/j.biopha.2022.112614_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.112614_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jinf.2020.06.052","article-title":"Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.biopha.2022.112614_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/rheumatology\/keaa587","article-title":"Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study","volume":"60","author":"Rodriguez-Garcia","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2022.112614_bib36","article-title":"The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: systematic review and meta-analysis","volume":"11","author":"Wijaya","year":"2021","journal-title":"Clin. Epidemiol. Glob. Health"},{"issue":"11","key":"10.1016\/j.biopha.2022.112614_bib37","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1007\/s10067-021-05884-4","article-title":"Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials","volume":"40","author":"Patoulias","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.biopha.2022.112614_bib38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112614_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108027","article-title":"Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: a systematic review and meta-analysis of randomized controlled trials","volume":"99","author":"Chen","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112614_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/dmd.113.054940","article-title":"The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans","volume":"42","author":"Dowty","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.biopha.2022.112614_bib41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with Covid-19 pneumonia","volume":"385","author":"Guimar\u00e3es","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biopha.2022.112614_bib42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/phar.2438","article-title":"Baricitinib: a review of pharmacology, safety, and emerging clinical experience in COVID-19","volume":"40","author":"Jorgensen","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"6504","key":"10.1016\/j.biopha.2022.112614_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biopha.2022.112614_bib44","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/eji.202049159","article-title":"Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 spike protein","volume":"51","author":"Palasiewicz","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112614_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12879-021-06015-9","article-title":"Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy","volume":"21","author":"Dentone","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2022.112614_bib46","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/jmv.26038","article-title":"Clinical outcomes in COVID-19 patients treated with tocilizumab: an individual patient data systematic review","volume":"92","author":"Antwi-Amoabeng","year":"2020","journal-title":"J. Med. Virol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:38:33Z","timestamp":1760099913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"alternative-id":["S0753332222000026"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112614","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112614"}}